Anne Graham monitors the FDA's influence on medicine, noting that agency decisions affect healthcare access in Maine.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Anne Graham →

  scientist

  Nothing else this week.

• Maine →

  tributary of the Loire in France

  • Communities are debating a proposed data center development at a former mill site, amid concerns over AI adoption and electricity consumption.Mon 09:04
  • NY Forward funding is driving project feasibility studies involving New York and Maine.Mon 09:04
• FDA →
  • FDA approval is the goal for product candidates from Daré Bioscience, Inc.Mon 14:53
  • NewcelX Ltd. advanced its IND-enabling work for a Phase 1/2a trial and held a successful Type B Pre-IND meeting with the FDA.Mon 14:50

Related events

• The FDA is facing public scrutiny due to oversight failures, leading to the introduction of new legislation targeting agency shortcomings.Sep 22
• CMS criticized Maine's Medicaid system for abuse.Aug 6